PAVmed Inc. Series Z Warrant
PAVMZ
PAVMZ was delisted on the 30th of April, 2025.
7 hedge funds and large institutions have $97K invested in PAVmed Inc. Series Z Warrant in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 7 → 7 (0)
48% less capital invested
Capital invested by funds: $185K → $97K (-$88K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCS
Levin Capital Strategies
New York
|
+$23.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$87.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$5.47K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$2.06K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WAM
1
Wolverine Asset Management
Chicago,
Illinois
| $45K | -$2.06K | -3,023 | -3% |
|
|
LCS
2
Levin Capital Strategies
New York
| $34K | +$23.5K | +34,550 | +81% |
|
|
WAM
3
Warberg Asset Management
Winnetka,
Illinois
| $17K | -$87.2K | -128,315 | -77% |
|
|
4
UBS Group
Zurich,
Switzerland
| $1K | -$5.47K | -8,050 | -82% |
|
PAVMZ Hedge Fund Activity: Q3 2022 in Review
7 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q3 2022, worth a combined $97K — down 48% from $185K a quarter earlier.
Fund positioning in PAVMZ was balanced in Q3 2022: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Levin Capital Strategies, adding an estimated $23.5K. The largest seller was Warberg Asset Management, cutting an estimated $87.2K.
- 7 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $97K of PAVmed Inc. Series Z Warrant stock for Q3 2022, down 48% quarter-over-quarter.
- 0 funds opened new PAVmed Inc. Series Z Warrant positions in Q3 2022 and 0 closed out.
- The largest PAVmed Inc. Series Z Warrant buyer in Q3 2022 was Levin Capital Strategies, an estimated $23.5K added.
- The largest PAVmed Inc. Series Z Warrant seller in Q3 2022 was Warberg Asset Management, an estimated $87.2K sold.
Based on aggregated 13F filings for Q3 2022.